Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
3.760
-0.070 (-1.83%)
At close: Nov 20, 2024, 4:00 PM
3.770
+0.010 (0.27%)
Pre-market: Nov 21, 2024, 7:33 AM EST
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $396.47 million as of November 21, 2024. Its market cap has decreased by -5.89% in one year.
Market Cap
396.47M
Enterprise Value
666.09M
1-Year Change
-5.89%
Ranking
Category
Stock Price
$3.76
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $396.47M, a decrease of -93.00%. That is a compound annual growth rate of -33.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 396.20M | -6.49% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quanterix | 422.94M |
| Rigel Pharmaceuticals | 420.38M |
| DocGo | 410.24M |
| Revance Therapeutics | 405.45M |
| Verve Therapeutics | 404.69M |
| Larimar Therapeutics | 401.98M |
| 4D Molecular Therapeutics | 400.79M |
| enGene Holdings | 397.75M |